QClamp™ JAK2 Codon Specific Mutation Detection Kit ... · QClamp JAK2 Codon Specific Mutation...
Transcript of QClamp™ JAK2 Codon Specific Mutation Detection Kit ... · QClamp JAK2 Codon Specific Mutation...
QClamp JAK2 Codon Specific Mutation Detection Kit
1
QClamp™ JAK2 Codon Specific Mutation Detection Kit
QClamp™ JAK2 Codon Specific Mutation Detection Kit
Instruction Manual
Rev. 5.0
For Real-Time PCR Assays
#DC -10-0166 (30 samples)
#DC-10-0165 (60 samples)
Date of Revision: November 21, 2013
DOC-DC1100166_DC1100165
DiaCarta Inc.
3535 Breakwater Ave., Hayward, CA 94545
TEL: (510) 314-8858 FAX: (510) 735-8636
E-MAIL: [email protected]
MDSS GmbH
Schiffgraben 41
30175 Hannover,
Germany
QClamp JAK2 Codon Specific Mutation Detection Kit
2
Contents
Components of the QClamp™ JAK2 Mutation Detection Kit .............................................. 3
Storage Requirements ............................................................................................................... 3
Intended Use .............................................................................................................................. 4
JAK2 Mutations and Cancer ................................................................................................... 4
QClamp Technology for Mutation Detection ...................................................................... 5
General Considerations ............................................................................................................ 6
Validated PCR Instruments for QClamp XNA Assays ......................................................... 6
Additional Equipment and Reagents Required .............................................................................. 7
Warnings and Precautions .................................................................................................................... 7
ASSAY PROCEDURE
Sample Preparation ....................................................................................................................... 8
DNA preparation from cells with Qzol reagent
Guidelines for using QZol Reagent on whole blood
Purified DNA sample (non-QZol)
Preparation and aliquoting of PCR mixes and samples ...................................................... 10
Set up mastermixes for assays in 96-well plate, tube strips, or tubes
Dispense master mix, samples, and Clamping Controls
Real-Time PCR Reaction ....................................................................................................... 12
ANALYSIS OF RESULTS
Assessment of Real-Time PCR Results ................................................................................. 13
Clamping Controls (wild-type DNA control)
Judging validity of sample data based on non-XNA mix results
Judging validity of sample data based on Internal Control of HRM Curves
Scoring Detected Mutations ................................................................................................... 15
Assay Performance Characteristics ...................................................................................... 16
Symbols Used in Packaging.................................................................................................... 19
Ordering Information ............................................................................................................. 19
Troubleshooting ...................................................................................................................... 20
References ............................................................................................................................... 22
QClamp JAK2 Codon Specific Mutation Detection Kit
3
KIT COMPONENTS TABLE 1. COMPONENTS OF KITS #DC-10-0166 AND #DC-10-0165
No.
Name of component
Description
Volume
(30 tests)
DC-10-0166
Volume
(60 tests)
DC-10-0165
Storage
1 Non XNA mix #1 Primers only 1 x 200 µl 1 x 400 µl -20°C
2 JAK2 XNA mix #2 Codon 617 XNA and primers 1 x 200 µl 1 x 400 µl -20°C
3 JAK2 XNA 2X premix PCR reaction premix 1 x 0.65 mL 2 x 0.65 mL -20°C
4 Clamping control Wild-type DNA 1 x 50 µl 1 x 100 µl -20°C
5 QZol Solution A Lysis Buffer A 2 x 1.0 ml 4 x 1.0 ml -20 ºC
6 QZol Solution B Lysis Buffer B 2 x 1.0 ml 4 x 1.0 ml -20 ºC
STORAGE REQUIREMENTS
The QClamp™ JAK2 Codon-Specific Mutation Detection Kit should be stored at -20°C.
QClamp JAK2 Codon Specific Mutation Detection Kit
4
INTENDED USE The QClamp™ JAK2 Codon Specific Mutation Detection Kit is used to detect somatic mutations in
codon 617 in the JAK2 tyrosine kinase gene (Table 2) from cell or tissues without DNA extractions.
The kit is to be used by trained laboratory professionals within a laboratory environment, using, for
example, fresh or formalin-fixed, paraffin-embedded (FFPE) samples of lung and colorectal biopsies
and surgical tissue samples.
TABLE 2. JAK2 MUTATIONS DETECTED BY THE KIT
JAK2 MUTATIONS AND CANCER
Janus kinase 2 (JAK2) is an intracellular tyrosine kinase that associates with the cytoplasmic domains
of multiple cytokine receptors. Ligand binding by the receptor results in conformational changes that
activate JAK2, resulting in phosphorylation of target proteins, including STATs and JAK2 itself. More
than 50% of myeloproliferative neoplasms (MPNs) harbor the activating JAK2 V617F mutation In
addition, a subset of B cell acute lymphoblastic leukemia (B-ALL) with rearrangements of cytokine
receptor–like factor 2 (CRLF2) have activating JAK2 mutations that primarily involve R683. A high
proportion (> 50%) of patients with myeloproliferative disorders (MPD; (polycythemia vera, essential
thrombocythemia, idiopathic myelofibrosis ) carry a dominant gain-of-function V617F mutation in the
JH2 kinase-like domain of JAK2. This mutation leads to deregulation of the kinase activity, and thus to
constitutive tyrosine phosphorylation activity. The V617F mutation seems to occur exclusively in
hematopietic malignancies of the myeloid lineage.
A significant percentage of patients with myeloproliferative disorders carries a dominant gain of
function V617F mutation in JAK2; this mutation seems to lead to deregulation of the kinase activity of
JAK2, and thus to constitutive tyrosine phosphorylation activity, providing hematopoietic cells with a
proliferative and survival advantage.
Reagent Target Exon Codon
JAK2 Mutation 12 617
QClamp JAK2 Codon Specific Mutation Detection Kit
5
QCLAMP™ TECHNOLOGY FOR MUTATION DETECTION
The QClamp™ JAK2 Codon Specific Mutation Detection Kit is based on Xeno-Nucleic Acid
(XNA)-mediated PCR clamping technology. XNA is a synthetic DNA analog in which the
phosphodiester backbone has been replaced by a repeat formed by units of (2-aminoethyl)-glycine.
XNA-mediated PCR clamping relies on the following two unique properties of XNA probes:
First, XNA will hybridize tightly to its complementary DNA target sequence only if the sequence
is a complete match. When there is a mutation in the target gene, and therefore a mismatch is present,
the XNA:DNA duplex is unstable, allowing strand elongation by DNA polymerase.
Second, XNA oligomers are not recognized by DNA polymerases and cannot be utilized as primers
in subsequent real-time PCR reactions. Instead, the XNA oligomer serves as a sequence-selective
clamp to prevent amplification during subsequent PCR reactions.
The assay is sufficiently robust that conventional nucleic acid purification is not required. Tissue or
cells can be simply lysed with the QZol™ reagent provided, then an aliquot of this extract is added
directly to the PCR mixture containing DNA primers and the XNA “clamp”.
FIGURE 1. PRINCIPLE OF THE QCLAMP™ JAK2 CODON-SPECIFIC MUTATION DETECTION KIT
The QClamp XNA oligonucleotide binds the wild-type DNA near the hybridization site of the forward
PCR primer, thus blocking the action of the DNA polymerase. Genetic variations at the QClamp
binding site will prevent tight binding of the QClamp oligonucleotide, permitting the polymerase chain
reaction to produce a detectable amplicon.
QClamp JAK2 Codon Specific Mutation Detection Kit
6
GENERAL CONSIDERATIONS Effective use of real-time PCR tests requires good laboratory practices, including maintenance of
equipment that is dedicated to molecular biology and is compliant with applicable regulations and
relevant standards. Use nuclease-free labware (pipets, pipet tips, reaction vials) and wear gloves when
performing the assay. Use fresh aerosol-resistant pipet tips for all pipetting steps to avoid cross
contamination of the samples and reagents.
Perform the QClamp assay protocol using only material (pipets, tips, etc.) dedicated to this application
in an area where no DNA matrixes (DNA, plasmid, or PCR products) have been introduced. Add
template DNA in a separate area (preferably a separate room) with material (pipets, tips, etc.) dedicated
only to this application. Use extreme caution to prevent DNase contamination that could result in
degradation of the template DNA, or DNA or PCR carryover contamination, which could result in a
false positive signal.
Reagents and instructions supplied in the kit have been tested for optimal performance. All reagents are
formulated specifically for use with this kit. Make no substitutions in order to insure optimal
performance of the kit. Further dilution of the reagents or alteration of incubation times and
temperatures may result in erroneous or discordant data.
VALIDATED REAL-TIME PCR INSTRUMENTS FOR QCLAMP XNA ASSAYS
The following instruments have been validated for use with QClamp XNA assays.
TABLE 3. REAL-TIME INSTRUMENTS TESTED WITH QCLAMP XNA ASSAYS
Company Model
Bio-Rad CFX 96
Roche LightCycler LC96
Roche LightCycler 480 II
ABI ABI 7500
ABI ABI 7900
Qiagen Rotor-Gene Q
Cepheid* SmartCycler
*Cepheid uses a 25 µl reaction volume. If using the Cepheid instrument, or for advice in optimizing
your protocol for other instruments, please contact DiaCarta.
Email: [email protected]
Tel: +1 510 314-8858
www.diacarta.com
QClamp JAK2 Codon Specific Mutation Detection Kit
7
ADDITIONAL EQUIPMENT AND REAGENTS REQUIRED
Real-time PCR instrument capable of SYBR Green dye detection
0.2 ml DNase-free PCR tubes or plates
Pipettes (P-20, P-200, P-1000, P-200 multi-channel)
1.5ml microcentrifuge tubes
15 ml conical tubes
Microcentrifuge
Vortexer
PCR rack
Reagent reservoir
Distilled water
WARNINGS AND PRECAUTIONS
Use extreme caution to prevent contamination of PCR reactions with the Clamping Control.
Minimize exposure of the XNA 2X premix to room temperature for optimal amplification.
Avoid overexposing the XNA 2X premix solution to light for optimal fluorescent signal.
Use of non-recommended reagent volumes may result in a loss of performance and may also
decrease the reliability of the test results.
Use of non-recommended volumes and concentrations of the target DNA sample may result in a
loss of performance and may also decrease the reliability of the test results.
Use of non-recommended consumables with instruments may adversely affect test results.
Do not re-use any remaining reagents after PCR amplification is completed.
Additional validation testing by user may be necessary when using non-recommended instruments.
Additional purification may be required if DNA has been extracted from a paraffin block.
Perform all experiments under proper sterile conditions using aseptic techniques.
Perform all procedures using universal precautions.
Wear personal protective apparel, including disposable gloves, throughout the assay procedure.
Do not eat, drink, smoke, or apply cosmetics in areas where reagents or specimens are handled.
Dispose of hazardous or biologically-contaminated materials according to the practices of your
institution.
Discard all materials in a safe and acceptable manner, in compliance with all legal requirements.
Dissolve reagents completely, then mix thoroughly by vortexing.
If exposure to skin or mucous membranes occurs, immediately wash the area with large amounts of
water. Seek medical advice immediately.
Do not use components beyond the expiration date printed on the kit boxes.
Do not mix reagents from different lots.
Return all components to the appropriate storage condition after preparing the working reagents.
Do not interchange vial or bottle caps, as cross-contamination may occur.
QClamp JAK2 Codon Specific Mutation Detection Kit
8
ASSAY PROCEDURE
Step 1: Sample preparation (30 min) Lyse samples with QZol to release genomic DNA Step 2: Add QClamp Mixture (10min) Add lysates or clamp controls to QClamp mix (2X Premix and XNA Mix)
Step 3: Real-Time PCR Reaction (2 hours)
FIGURE 2. WORKFLOW OF THE QCLAMP JAK2 CODON SPECIFIC MUTATION DETECTION KIT
Use standard pathology methodology to ensure specimen quality during collection, transport and
storage of samples. Alternate methodology for sample handling must be validated by the enduser.
1. SAMPLE PREPARATION QZol™ Reagent is a complete and ready-to-use lysis reagent consisting of QZol Solutions A and B.
QZol releases genomic DNA from solid and liquid samples of animal, plant, yeast, and bacterial origin
into a form which can be used directly in PCR reactions without the need for DNA extraction. In
addition, the special properties of Qzol„s chemistry can help keep DNA in linear format to optimize
hybridization and increase PCR efficiency.
Typical sources of genomic DNA for mutation detection by the kit include samples obtained from
whole blood, purified peripheral blood lymphocytes, polynuclear cells, or granulocytes, fresh or frozen
tissue from surgical procedures and biopsies. QZol has been validated on these sample types, as well as
on cultured cells and cells purified from blood such as peripheral blood lymphocytes, polynuclear cells,
and granulocytes. An extraction procedure for whole blood with the reagent has not yet been validated,
but should work with some optimization depending on coagulant used, etc. Contact DiaCarta at
[email protected] for assistance with genomic DNA protocol optimization.
Other methods for purifying genomic DNA, such as homebrew methods or commercially-available
products, will also work with the kit. Regardless of which approach is used, use the same cellular
fraction and DNA extraction method each time the assay is performed.
DNA preparation from cells with QZol reagent
For softer and moister tissues such as cultured cells or cells purified from blood such as peripheral blood
lymphocytes, polynuclear cells, and granulocytes, modify the protocol to add twice the volume of QZol
reagent as sample volume.
QClamp JAK2 Codon Specific Mutation Detection Kit
9
1. Thaw QZol Solution A and QZol Solution B at room temperature or in a water bath
2. Add anywhere from 200 to 100,000 cells to a microcentrifuge tube, ideally a sample volume of
approximately 50 µl. The sample to reagent volume ratio for these tissue types should be roughly 1:2.
3. Add 100 µl of QZol Solution A to each tube and vortex for 10 seconds.
4. Place sample tubes into a heating block at 95 °C for 20 minutes, removing every 5 minutes to vortex
10 seconds.
5. Remove sample tubes from heating block and add an equivalent volume of QZol Solution B as was
added of QZol Solution A. If 100 µL of Solution A was added earlier, now add 100 µl of Solution B.
6. Vortex each sample for 10 seconds.
7. Spin down the sample preparation tubes for 30 seconds in a microcentrifuge.
8. Collect the supernatant, the QZol lysate, avoiding the pellet, for use in PCR procedure, cool to room
temperature.
Guidelines for using QZol Reagent on Whole Blood
A generalized extraction procedure for QZol Reagent on whole blood has not been established. Whole
blood is a complex tissue and different coagulation reagents produce final products with varying
characteristics. However, a reasonable starting point would be the incubation protocol for cells on a
sample size of 200 µl whole blood along with 400 µl each of Solution A and Solution B. Contact
DiaCarta at [email protected] for assistance with whole blood protocol optimization.
Purified DNA Sample (non-QZol)
The QClamp real-time PCR reaction is optimized for DNA samples containing 5-10 ng of purified
genomic DNA. If you are working with samples consisting of purified DNA, dilute the DNA to a
concentration of 5 ng/μl in 1X TE buffer at pH 8.0. Store samples at +4 to +8 °C for short periods, up to
one week. Store at –20 °C if longer-term storage is required.
2. PREPARATION AND ALIQUOTING OF PCR MIXES AND SAMPLES
Each sample of potentially mutant DNA requires one reaction for each mutation site detected by the kit,
plus an XNA-free control. The XNA-free control insures that the supplied primers and polymerase are
working properly on the sample. The JAK2 Codon-Specific Mutation Detection Kit detects mutation
sites in exon 12, therefore a total of two reactions will be required for each sample.
A set of Clamping Controls must also be run every time the assay is run. Clamping Controls use
wild-type DNA as the sample. Wild-type DNA should have no mutations, therefore the XNA probes
will bind strongly, blocking the polymerase from making amplicons. However, non-XNA mix #1 with
the Clamping Control should make amplicons efficiently, providing another way to monitor
performance of the primers, polymerase, and sample.
QClamp JAK2 Codon Specific Mutation Detection Kit
10
Each kit contains enough material to run five sets (30-sample test kit) or ten sets (60-sample test kit) of
Clamping Controls, or one Clamping Control set for every six samples. Further quantities of JAK2
wild-type genomic reference DNA control can be purchased as a separate item, if desired.
Depending on how many samples will be processed in a given experiment, different strategies are used
for creating master mixes. The most typical application involves testing in 96-well plates, but the assay
can also be run in tube strips or individual tubes.
The QClamp XNA real-time assay protocol uses 20 μl reaction volumes. Each reaction will contain 10
μl 2X Premix, 6 μl of one of each XNA Mix, and 4 μl of sample, for a total of 20μl.
Adjust amounts appropriately for different reaction volumes.
TABLE 4. COMPONENTS OF THE QCLAMP XNA ASSAY REACTION VOLUME
Components Volume
JAK2 XNA 2X Premix 10 μl
XNA Mix (#1, #2) 6 μl
DNA sample or Clamping Control 4 μl
Total volume 20 μl
QClamp JAK2 Codon Specific Mutation Detection Kit
11
Set up mastermixes for assays in 96-well plate, tube strips, or tubes
(This is a suggested method. Other approaches can achieve the final result.)
1. Consecutively label two tubes as M1, and M2.
These will be master mix tubes containing XNA Mixes #1, and #2 respectively, plus the 2X PreMix
(containing polymerase, SYBR Green and appropriate buffers).
Tip: It is good practice to go 10% over when putting master mixes together to insure not running out of
master mix prematurely when aliquotting.
2. Add the appropriate amount of 2X Premix and XNA Mix to its M tube. See table 5 for
appropriate volumes.
TABLE 5. SETTING UP PCR REACTION MASTER MIXES
# samples
(Volume calculated
based on N+2
samples to account
for clamping control
and overage)
Non-XNA Mix #1 (S1) or
JAK2 XNA Mix #2 (S2)
JAK2 XNA 2X
Premix
Total Volume Sample volume
10 72 µl 120 µl 192 µl Add 16 µl to each
tube, then add 4 µl of
sample to the
appropriate tubes.
20 132 µl 220 µl 352 µl
30 172 µl 320 µl 492 µl
40 252 µl 420 µl 672 µl
50 312µl 520 µl 832 µl
60 372 µl 620 µl 992 µl
Table 5 is based on the following calculations to determine the number of microliters of each XNA Mix
and 2X Premix to aliquot to its respective master mix tube, where N = total number of samples. For
sample amounts not indicated in Table 5, the following calculations may be used:
(N + 2) x 6 = Microliters of XNA Mix for each master mix tube of the corresponding number.
(N+2) x 10 = Microliters of 2X Premix in every master mix tube.
(The N+2 calculation is to account for the Clamping Controls and overage.)
Dispense master mix, samples, and Clamping Controls
3. Dispense 16 µl master mix across a 96-well plate or into tubes
Transferring the contents of each master mix tube to a reagent reservoir now enables use of a
multichannel pipettor in dispensing across a plate or into strips.
Alternatively, a repeating pipettor would be useful for an individual tubes assay format.
In the case of 96-well plates, the exact plate layout for the next step can be set to the user‟s preference.
However, take care to remember which wells are for which XNA Mixes, to insure that all potential
detected mutations and XNA minus controls are processed properly.
QClamp JAK2 Codon Specific Mutation Detection Kit
12
A suggested layout involves using a 8-channel pipettor to pipet 16 µl of master mix into the columns on
the plate, that is, to pipet 16 µl of M1 into columns 1, 5, and 9, 16 µl of M2 in columns 2, 6, and 10, and
so on.
6 ul NonXNA Mix #1
6 ul XNA
Mix #2
6 ul Non XNA
Mix #1
6 ul XNA
Mix #2
6 ul NonXNA Mix #1
6 ul XNA Mix
#2
6 ul Non-XNA
Mix #1
6 ul XNA Mix #2
1 2 3 4 5 6 7 8
A
SAMPLE 1
SAMPLE 1
SAMPLE 2
SAMPLE 2
SAMPLE 3 SAMPLE 3 SAMPLE 4 SAMPLE 4
B
SAMPLE 5
SAMPLE 5
SAMPLE 6
SAMPLE 6
SAMPLE 7 SAMPLE 7 SAMPLE 8 SAMPLE 8
C
SAMPLE 9
SAMPLE 9
SAMPLE 10
SAMPLE 10
SAMPLE 11
SAMPLE 11
SAMPLE 12
SAMPLE 12
D
SAMPLE 13
SAMPLE 13
SAMPLE 14
SAMPLE 14
SAMPLE 15
SAMPLE 15
SAMPLE 16
SAMPLE 16
E
SAMPLE 17
SAMPLE 17
SAMPLE 18
SAMPLE 18
SAMPLE 19
SAMPLE 19
SAMPLE 20
SAMPLE 20
F
SAMPLE 21
SAMPLE 21
SAMPLE 22
SAMPLE 22
SAMPLE 23
SAMPLE 23
SAMPLE 24
SAMPLE 24
G
SAMPLE 25
SAMPLE 25
SAMPLE 26
SAMPLE 26
SAMPLE 27
SAMPLE 27
SAMPLE 28
SAMPLE 28
H
SAMPLE 29
SAMPLE 29
SAMPLE 30
SAMPLE 30
CLAMPING CONTROL
CLAMPING CONTROL
10 ul 2X Premix, all wells
FIGURE 3. SUGGESTED PLATE LAYOUT
4A. Dispense 4 µl of sample DNA and Clamping Control DNA into wells
With a plate layout as described in Figure 3, where each column represents a different XNA Mix, use two
pipet tips on an 8-channel pipettor or a repeating pipettor with a single tip to pipet 4 µl of Sample 1 into
each of the first two wells of Row A, then 4 µl of Sample 2 into each of the next two wells in that row, and
so on, until all samples are loaded.
Pipet the clamping controls into the last two wells of Row H.
4B. Dispense 4 µl of sample DNA and Clamping Control DNA into tubes
If pipetting samples into tubes instead of 96-well plates, label tubes as “S” followed by the number of the
mix (1 or 2), a hyphen, then the sample number. For example, if running 15 samples, label tubes as S1-1,
S1-2 …..S1-15. Repeat for S2. Label the single set of Clamping Control reaction tubes as C1and C2.
When all reagents have been loaded, tightly close the PCR tubes or seal the 96-well plate to prevent
evaporation.
QClamp JAK2 Codon Specific Mutation Detection Kit
13
3. REAL-TIME PCR REACTION Set up the real-time PCR instrument to read SYBR Green at 60 °C. Perform real-time PCR using the
cycling conditions described below.
TABLE 6. CYCLING CONDITIONS FOR QCLAMP XNA ASSAYS
One cycle
Pre-denaturation 95 °C 5 minutes
Four-step cycling (40 cycles total)
Denaturation 95 °C 30 seconds
QClamping 70 °C 20 seconds
Primer annealing 58 °C 30 seconds
Extension 60 °C 30 seconds
ANALYSIS OF RESULTS
ASSESSMENT OF REAL-TIME PCR RESULTS
Determine the Cq value for each PCR reaction. Cq is the cycle threshold, the cycle number at which
a signal is detected above background fluorescence. The lower the cycle number at which signal rises
above background, the stronger the PCR reaction it represents (**please see MIQE Guidelines under
References).
Clamping Controls (wild-type DNA control)
The Cq values of the Clamping Controls (tubes C1-C2) should fall in the range given in the table below.
These values are expected because the combination of wild-type DNA with XNA probes in C2 should
block amplification, while the absence of probes in C1 would produce a robust level of amplification.
The assay should be repeated if the values are not within the recommended range.
TABLE 7. ACCEPTABLE CQ RANGES FOR THE CLAMPING CONTROLS
Assay Acceptable Cq Range
Non-XNA mix #1 (C1) 23 ≤ Cq ≤ 30
JAK2 XNA mix #2 (C2) > 34
QClamp JAK2 Codon Specific Mutation Detection Kit
14
Judging validity of sample data based on non-XNA mix results
In considering the Cq values for each sample (S1-S2), note that the Cq values of any non-XNA mix #1
reaction should be in the range of 22-34. The Cq value of non-XNA mix #1 (S1) can serve as an internal
control to indicate the purity and the concentration of DNA. Thus, the validity of the test can be decided
by the Cq value of the non-XNA mix #1 (S1).
TABLE 8. NON-XNA CONTROLS FOR SAMPLE PURITY AND CONCENTRATION
Validity Cq value of
non-XNA mix #1 Descriptions and recommendations
Optimal 23 < Cq < 30 The amplification and amount of DNA sample were
optimal.
Acceptable 30 < Cq < 34 The target gene was amplified at low efficiency. For a more
reliable result, repeat the PCR reaction with more DNA.
Invalid Cq ≤22 Possibility of a false positive is high. Repeat the PCR
reaction with less DNA.
Invalid Cq ≥ 34 The amplification has failed. Check DNA amount and
purity. A new DNA prep may be required.
Judging validity of sample data based on Internal Control of HRM curves
If test sample is negative, please check the HRM melting profile derivative plots ( -dF/dT against
T) to make sure it is true negative.
1. The -dF/dT should be 0.10 or higher
2. If the -dF/dT is less than 0.10, PCR reaction is inhibited, the obtained data must be
discarded and the experiment should be repeated.
Normal PCR reaction HRM profiles:
Sample 1
-dF/dT > 0.3
QClamp JAK2 Codon Specific Mutation Detection Kit
15
Sample 2
-dF/dT > 0.3
-dF/dT = < 0.10 PCR reaction inhibited.
SCORING DETECTED MUTATIONS
After measuring and recording the Cq values for each reactions of each sample and all
Clamping Control reactions, next determine ΔCq values for mutation sites in every sample.
Subtract the Cq of each sample that contained XNA Mix#2 from the Cq of Clamping Control 2
to get that set of ΔCq values.
Mutated samples are defined by conditions where the mutated allele yields Cq < 40, and the
ΔCq relative to the Clamped Control using the same XNA probe > 1.5. For example, if the Cq
of the C2 Clamping Control is 39 and the Cq of sample S1-2 is 35, then the ΔCq = 39 - 35 = 4.0,
or >1.5, so the sample is scored positive for a mutation.
If performing sample replicates, calculate the mean ΔCq for each sample, the standard
deviation (SD), and the mutation threshold (MT) value, where MT = mean ΔCq−2SD.
QClamp JAK2 Codon Specific Mutation Detection Kit
16
ASSAY PERFORMANCE CHARACTERISTICS
Analytical performance
The specific performance characteristics of the QClamp JAK2 Mutation Detection kit were
determined by studies involving JAK2 defined genomic DNA reference samples obtained from
Horizon Diagnostics (Cambridge, England) these are genetically defined JAK2 genomic DNA
that contain heterozygous mutations in the coding sequence of the JAK2 gene at codons described
in Table 2. These single nucleotide polymorphisms in the JAK2 gene are confirmed by droplet
digital PCR (ddPCR) and genomic DNA sequencing. Mutation status of samples are confirmed
by sequencing.
Analytical accuracy and comparison to reference method
QClamp analytical accuracy is verified and validated through testing of samples with known
mutations. Sample mutation status was verified through sequencing. Three studies were done to
demonstrate concordance in mutation status of samples tested with QClamp Mutation Detection
Kit relative to sequencing. A set of sample were chosen for evaluation based on mutation status. In
a blinded manner, samples were chosen to be tested with QClamp Mutation Detection Kit to be
compared to mutation status returned from sequencing. The results demonstrated that the QClamp
Mutation Detection Kit reported 100% match to sequencing. The results are confirmed by
performance from three different test sites and three different sets of clinical samples.
Cut-off
Along with studies for analytical accuracy, samples were tested to establish cut-off for the assay.
Cut-off for positive mutation has been established at ΔCq > 1.5.
Interfering substances
The objective of this study was to evaluate the impact of potentially interfering substances
on the performance of the QClamp JAK2 Mutation Detection Kit. The impact of each substance
was analyzed by means of spiking experiments at three concentrations on the results of ΔCq and
the mutation status of test samples. Potentially interfering substances tested were paraffin, ethanol,
QZol Solution A, QZol Solution B, Assay Buffer, and Proteinase K at the concentration of 0.1%,
1% and 5%. None of the potentially interfering substances evaluated at the concentrations
expected to be encountered in normal use impacts the ability of the QClamp JAK2 Mutation
Detection Kit to distinguish between mutation-positive and mutation-negative samples.
Multiple freeze/thaw cycles
The effect of 1, 3, 5, and 8 freeze-thaw cycles were tested in QClamp JAK2 Mutation Detection Kit
reagents. There is no effect up to 5 freeze-thaw cycles on the QClamp JAK2 Mutation Detection Kit to
distinguish between mutation positive and mutation negative samples. Caution: Repeated freeze-thaw
cycles may decrease the reliability of test results.
Shelf-Life
6 months after kit is open; 1 year after receiving for unopened kit.
QClamp JAK2 Codon Specific Mutation Detection Kit
17
Repeatability and reproducibility
The precision of QClamp JAK2 Mutation Detection Kit was determined with defined analyte
levels of mutated DNA. To establish lot to lot variation, a reproducibility study of QClamp
Mutation Detection was performed using three different kit lots. Each lot was tested on three
separate dates testing one wild-type and one sample for each mutation with the QClamp JAK2
Mutation Detection Kit. Inter-assay %CV was established using the same lot of reagents tested
by three different users, performed at three different sites, with tests run one-two times a day for
three days. Intra-assay %CV was established through performance of QClamp Mutation
Detection Kit with samples run in triplicate and repeated for three days. All testing was done
using sequence verified samples from Horizon Diagnostics. Reproducibility is demonstrated
based on %CV of Cq values with a rate of 100% correct mutation calls for all assays across
multiple lots and operators for both within and between laboratory experiments.
TABLE 9. REPRODUCIBILITY RESULT SUMMARY %CV
Limit of Detection
To determine the limit of detection (LOD) for the kit, a QClamp assay was run using a
serial dilution of mutant DNA in wild-type background. Mutant samples were sequence verified
by Horizon Diagnostics. Mutant concentrations tested were 50, 10, 5, 1, and 0.1% Results
demonstrate effective clamping of wild type, providing reproducible detection of mutations at
concentrations as low as 0.1%.
Mutant Dilution Study:
ΔCq 0.1% Mutant = 1.65 ΔCq = Cq of negative control – Cq of sample
ΔCq 1.0 % Mutant = 3.0 ΔCq = Cq of negative control – Cq of sample
Intra-assay ≤ 3%
Inter-assay ≤ 5%
Lot to Lot variation ≤ 3%
QClamp JAK2 Codon Specific Mutation Detection Kit
18
Using Roche LC96
Profile of WT DNA Control
Profile of samples and controls
Understanding the Symbols
WT without
QClamping
WT with
Qclamping
QClamp JAK2 Codon Specific Mutation Detection Kit
19
SYMBOLS USED IN PACKAGING
TABLE 10. SYMBOLS USED IN PACKAGING
Symbol Definition
In Vitro diagnostic device
Catalog Number
Manufactured by
Temperature limitation
Batch Code
Use by date
Authorized Representative in the European
Community
CE Mark
2012-11-25 Date format (year-month-day)
2012-11 Date format (year-month)
ORDERING INFORMATION: TABLE 11. ORDERING INFORMATION
QClamp™ JAK2 Codon-Specific Mutation Detection Kit
Product Name Cat.Number Size Reader
Platform JAK2 Mutations
QClamp™ JAK2 Codon Specific
Mutation Detection Kit DC-10-0166
30
samples
Real-time
PCR
Analysis
Mutations in Exon 12
codons 617
QClamp™ JAK2 Codon Specific
Mutation Detection Kit DC-10-0165
60
samples
Real-time
PCR
Analysis
Mutations in Exon 12
codons 617
QClamp JAK2 Codon Specific Mutation Detection Kit
20
TROUBLESHOOTING:
Negative result for Clamping Control with Non-XNA Mix #1
Possible Cause Recommended Solutions
Pipetting error Check pipetting scheme and setup of the reaction. Repeat the PCR run
Inappropriate storage of kit components
Store all kit components at appropriate temperature according to label, also see Kit Components Table (Table 1)
No signal (even in Clamping Controls with Non-XNA Mix #1)
Possible Cause Recommended Solutions
Pipetting error or omitted reagents Check pipetting scheme and the setup of the reaction. Repeat the PCR run
Inhibitory effects of the sample material, caused by insufficient purification
Repeat the RNA preparation.
See manual section “Judging validity of sample data based on
Internal Control of HRM curves”
Fluorescence intensity too low
Possible Cause Recommended Solutions
Inappropriate storage of kit components
Store all kit components at appropriate temperature according to label, also see Kit Components Table (Table 1)
Very low initial amount of target DNA
Increase the amount of sample DNA (Depending on chosen method of DNA preparation, inhibitory effects may occur)
No amplification curve and no PCR product visible on a gel
Possible Cause Recommended Solutions
PCR inhibitors present in the reaction mixture
Re-purify template DNA
Inhibition by excess volume of the RT reaction
Volume of the RT reaction product added to qPCR reaction should not exceed 10% of the total qPCR reaction volume
Pipetting error or missing reagent Repeat the PCR reaction; check the concentrations of template and primers; ensure proper storage conditions of all reagents
Annealing temperature is not optimal
Optimize the annealing temperature in 3°C increments
No amplification curve but PCR product visible on a gel
Possible Cause Recommended Solutions
qPCR instrument settings are incorrect
Check if instrument settings are correct (dye selection, reference dye, filters)
Inactive fluorescence detection Fluorescent detection should be activated and set at extension or annealing/extension step of the thermal cycling protocol
Instrument problems Refer to the instrument manual for troubleshooting
PCR efficiency is >110%
Possible Cause Recommended Solutions
Non-specific products Use melting curve analysis
QClamp JAK2 Codon Specific Mutation Detection Kit
21
PCR efficiency is <90%
Possible Cause Recommended Solutions
PCR inhibitors present in a reaction mixture
Re-purify template DNA
Non-uniform fluorescence intensity
Possible Cause Recommended Solutions
Contamination of the thermal cycler Perform decontamination of your real-time cycler according to the supplier‟s instructions
Poor calibration of the thermal cycler Perform calibration of the real-time cycler according to the supplier‟s instructions
QClamp JAK2 Codon Specific Mutation Detection Kit
22
REFERENCES
1. Levine, R.L., A. Pardanani, A. Tefferi, and D.G. Gilliland. 2007. Role of JAK2 in
the pathogenesis and therapy of myeloproliferative disorders. Nat. Rev. Cancer.
7:673–683. http://dx.doi.org/10.1038/nrc2210
2. Levine, R.L., M. Wadleigh, J. Cools, B.L. Ebert, G. Wernig, B.J. Huntly, T.J.
Boggon, I. Wlodarska, J.J. Clark, S. Moore, et al. 2005. Activating mutation in
the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and
myeloid metaplasia with myelofibrosis. Cancer Cell. 7:387–397.
http://dx.doi.org/10.1016/j.ccr.2005.03.023
3. Mullighan, C.G., J. Zhang, R.C. Harvey, J.R. Collins-Underwood, B.A. Schulman,
L.A. Phillips, S.K. Tasian, M.L. Loh, X. Su, W. Liu, et al. 2009b. JAK mutations in
high-risk childhood acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA.
106:9414–9418. http://dx.doi.org/10.1073/pnas.0811761106
4. Ørum, Henrik., PCR Clamping.. Curr. Issues Mol. Biol. 2000; 2(1), 27-30.
5. Powell et. al., Detection of the hereditary hemochromatosis gene mutation by real-time
fluorescence polymerase chain reaction and peptide nucleic acid clamping. Analytical
Biochemistry 1998; 260: 142–8.
6. Scott, L. M., The JAK2 Exon 12 Mutations: A Comprehensive Review. Am. J.
Hematol. 2011, 86, 668-6766
7. Weigert, O. et. al. Genetic Resistance to JAK2 Enzymatic Inhibitors is overcome
by HSP90 Inhibition. The Journal of Experimental Medicine, January 2012, 209
(2), 259-273.
8. **MIQE Reference: "The MIQE Guidelines: Minimum Information for
Publication of Quantitative Real-Time PCR Experiments". Stephen A. Bustin et.
al., Clin Chem. 55 (4): 611–22 (2009). http://www.clinchem.org/content/55/4/611
DiaCarta Inc.
3535 Breakwater Ave.
Hayward, CA94545 Email: [email protected]
Tel: +1 510 314-8858
Fax:+1 510 735 8636
www.diacarta.com